Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Tsuchiya · SciRah

Researcher profile · Semantic Scholar

K. Tsuchiya

Share profile

K. Tsuchiya — researcher profile on SciRah

h-index: 38
Works: 262
Citations: 5,563

Most-cited papers

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)
K. Hasegawa, N. Takemura, T. Yamashita, T. Watadani +23 more
2023Hepatology Research315 citations Open access
Semantic Scholar
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study
M. Kudo, T. Aoki, K. Ueshima, K. Tsuchiya +18 more
2023Liver Cancer142 citations Open access
Semantic Scholar
IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III Study
M. Kudo, R. Finn, P. Galle, A. Zhu +7 more
2022Liver Cancer77 citations Open access
Semantic Scholar
Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality
M. Higuchi, N. Tamaki, M. Kurosaki, Kento Inada +15 more
2021Alimentary Pharmacology and Therapeutics59 citations Open access
Semantic Scholar
Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma
Sakura Kirino, K. Tsuchiya, M. Kurosaki, S. Kaneko +17 more
2020PLoS ONE59 citations Open access
Semantic Scholar
Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice
Yuka Hayakawa, K. Tsuchiya, M. Kurosaki, Y. Yasui +20 more
2021Investigational new drugs55 citations Open access
Semantic Scholar
Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease
N. Tamaki, M. Kurosaki, Yuka Takahashi, Yoshie Itakura +15 more
2021Journal of Gastroenterology and Hepatology54 citations
Semantic Scholar
Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma
H. Ochi, M. Kurosaki, K. Joko, Toshie Mashiba +20 more
2022Hepatology Research47 citations Open access
Semantic Scholar
The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study
K. Tsuchiya, M. Kurosaki, A. Sakamoto, H. Marusawa +22 more
2021Cancers47 citations Open access
Semantic Scholar
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD
M. Ikeda, T. Yamashita, S. Ogasawara, M. Kudo +12 more
2023Liver Cancer37 citations Open access
Semantic Scholar
Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis
S. Kaneko, K. Tsuchiya, Y. Yasui, Kento Inada +19 more
2020Hepatology Research34 citations
Semantic Scholar
Risk difference of liver-related and cardiovascular events by liver fibrosis status in nonalcoholic fatty liver disease
N. Tamaki, M. Higuchi, M. Kurosaki, R. Loomba +15 more
2021Clinical Gastroenterology and Hepatology33 citations Open access
Semantic Scholar
Concordance between metabolic dysfunction‐associated steatotic liver disease and nonalcoholic fatty liver disease
Keito Suzuki, N. Tamaki, M. Kurosaki, Yuka Takahashi +15 more
2024Hepatology Research31 citations
Semantic Scholar
Atezolizumab plus Bevacizumab versus Sorafenib for Unresectable Hepatocellular Carcinoma: Results from Older Adults Enrolled in the IMbrave150 Randomized Clinical Trial
Da-Neng Li, H. Toh, P. Merle, K. Tsuchiya +4 more
2022Liver Cancer31 citations Open access
Semantic Scholar
Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma
Hiroaki Matsumoto, K. Tsuchiya, H. Nakanishi, Yuka Hayakawa +19 more
2022Cancers27 citations Open access
Semantic Scholar
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study
M. Kudo, K. Tsuchiya, N. Kato, A. Hagihara +11 more
2021Journal of gastroenterology27 citations Open access
Semantic Scholar
Prognosis of intrahepatic cholangiocarcinoma stratified by albumin–bilirubin grade
S. Kaneko, M. Kurosaki, K. Tsuchiya, Y. Yasui +17 more
2021Hepatology Research24 citations
Semantic Scholar
Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib
S. Kaneko, K. Tsuchiya, M. Kurosaki, Sakura Kirino +21 more
2020Hepatology Research23 citations
Semantic Scholar
Hepatitis B core‐related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen‐negative chronic hepatitis B patients
S. Kaneko, M. Kurosaki, Kento Inada, Sakura Kirino +14 more
2021Journal of Gastroenterology and Hepatology22 citations
Semantic Scholar
Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B
N. Tamaki, M. Kurosaki, H. Nakanishi, J. Itakura +16 more
2020Journal of Medical Virology20 citations
Semantic Scholar
Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog
Sakura Kirino, N. Tamaki, S. Kaneko, M. Kurosaki +18 more
2020Journal of Gastroenterology and Hepatology20 citations
Semantic Scholar
Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction‐associated steatotic liver disease
N. Tamaki, Shun-Ichi Wakabayashi, Takefumi Kimura, Y. Yasui +6 more
2024Hepatology Research19 citations
Semantic Scholar
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
Shun Ishido, N. Tamaki, Yuka Takahashi, N. Uchihara +15 more
2023BMC Gastroenterology19 citations Open access
Semantic Scholar
Attenuation coefficient (ATT) measurement for liver fat quantification in chronic liver disease
N. Tamaki, M. Kurosaki, Y. Yasui, K. Tsuchiya +1 more
2021Journal of medical ultrasonics18 citations
Semantic Scholar
Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group
S. Takaki, M. Kurosaki, N. Mori, K. Tsuji +21 more
2023Investigational new drugs16 citations
Semantic Scholar
Optimal threshold of alpha-fetoprotein response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab
N. Tamaki, T. Tada, M. Kurosaki, Y. Yasui +23 more
2022Investigational new drugs16 citations
Semantic Scholar
Impact of immune‐related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Keito Suzuki, Y. Yasui, K. Tsuchiya, Hiroaki Matsumoto +18 more
2024Journal of Gastroenterology and Hepatology14 citations
Semantic Scholar
Primary analysis of a phase II study of atezolizumab plus bevacizumab for TACE-unsuitable patients with tumor burden beyond up-to-seven criteria in intermediate-stage hepatocellular carcinoma: REPLACEMENT study.
K. Ueshima, M. Kudo, K. Tsuchiya, Naoya Kato +16 more
2023Journal of Clinical Oncology14 citations Open access
Semantic Scholar
Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation
N. Rohr-Udilova, K. Tsuchiya, G. Timelthaler, Martina Salzmann +11 more
2021Hepatology Communications14 citations Open access
Semantic Scholar
O-8 Atezolizumab + bevacizumab vs sorafenib for unresectable hepatocellular carcinoma: Results from older adults enrolled in IMbrave150
Da-Neng Li, H. Toh, P. Merle, K. Tsuchiya +5 more
202014 citations Open access
Semantic Scholar
Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment
S. Kaneko, K. Tsuchiya, Y. Yasui, Yuki Tanaka +19 more
2022JGH Open13 citations Open access
Semantic Scholar
Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC
R. Kohya, G. Suda, M. Ohara, Shunichi Hosoda +30 more
2025JHEP Reports12 citations Open access
Semantic Scholar
Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis
N. Tamaki, K. Takaura, M. Higuchi, Y. Yasui +5 more
2024Diagnostics12 citations Open access
Semantic Scholar
Clinical Utility of Comprehensive Genomic Profiling in Patients with Unresectable Hepatocellular Carcinoma
Shun Ishido, K. Tsuchiya, Y. Kano, Y. Yasui +19 more
2023Cancers10 citations Open access
Semantic Scholar
Real-World Data on Ramucirumab Therapy including Patients Who Experienced Two or More Systemic Treatments: A Multicenter Study
Y. Yasui, M. Kurosaki, K. Tsuchiya, Yuka Hayakawa +17 more
2022Cancers10 citations Open access
Semantic Scholar
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma
S. Kaneko, M. Kurosaki, K. Tsuchiya, Y. Yasui +17 more
2022PLoS ONE10 citations Open access
Semantic Scholar
Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy
Shuhei Sekiguchi, K. Tsuchiya, Y. Yasui, Kento Inada +16 more
2022Cancer Reports10 citations Open access
Semantic Scholar
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis
Kento Inada, S. Kaneko, M. Kurosaki, Koji Yamashita +15 more
2021JGH Open10 citations Open access
Semantic Scholar
Changes of liver stiffness measured by magnetic resonance elastography during direct‐acting antivirals treatment in patients with chronic hepatitis C
M. Higuchi, N. Tamaki, M. Kurosaki, Kento Inada +14 more
2020Journal of Medical Virology10 citations
Semantic Scholar
Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma
N. Tamaki, N. Mori, S. Takaki, K. Tsuji +20 more
2024Anticancer Research9 citations Open access
Semantic Scholar
Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein but not α-Fetoprotein as a Long-Term Hepatocellular Carcinoma Predictor
Leona Osawa, N. Tamaki, M. Kurosaki, Sakura Kirino +15 more
2020International Journal of Molecular Sciences9 citations Open access
Semantic Scholar
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study
Naoya Kato, M. Kudo, K. Tsuchiya, A. Hagihara +10 more
2023Hepatology Research8 citations Open access
Semantic Scholar
Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment
Sakura Kirino, N. Tamaki, M. Kurosaki, Kento Inada +14 more
2021Journal of Viral Hepatitis8 citations
Semantic Scholar
Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study Group
K. Tsuji, N. Tamaki, M. Kurosaki, N. Mori +16 more
2025Hepatology Research7 citations
Semantic Scholar
Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by Tolvaptan
Leona Osawa, H. Nakanishi, M. Kurosaki, Sakura Kirino +19 more
2021Digestive Diseases7 citations
Semantic Scholar
937P Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD
M. Ikeda, T. Yamashita, S. Ogasawara, M. Kudo +12 more
2021Annals of Oncology7 citations Open access
Semantic Scholar
Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B
Sakura Kirino, N. Tamaki, M. Kurosaki, S. Kaneko +18 more
2022Hepatology Research6 citations
Semantic Scholar
Validation of magnetic resonance elastography plus fibrosis‐4 for significant fibrosis in nonalcoholic fatty liver disease
Kento Inada, N. Tamaki, M. Kurosaki, Sakura Kirino +10 more
2022Journal of Gastroenterology and Hepatology6 citations
Semantic Scholar
Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis.
N. Tamaki, M. Kurosaki, M. Higuchi, Sakura Kirino +13 more
2020Hepatology Research6 citations
Semantic Scholar
Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib
S. Kaneko, K. Tsuchiya, Y. Yasui, Kento Inada +17 more
2020JGH Open6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Izumi×39
Invite
N. Izumi — researcher profile on SciRah
N. Tamaki×36
Invite
N. Tamaki — researcher profile on SciRah
M. Kurosaki×34
Invite
M. Kurosaki — researcher profile on SciRah
K. Takaura×28
Invite
K. Takaura — researcher profile on SciRah

×27

Invite

M. Higuchi — researcher profile on SciRah

C. Maeyashiki×26

Invite

C. Maeyashiki — researcher profile on SciRah

Yuka Takahashi×25

Invite

Yuka Takahashi — researcher profile on SciRah

H. Nakanishi×25

Invite

H. Nakanishi — researcher profile on SciRah

Yuka Hayakawa×24

Invite

Yuka Hayakawa — researcher profile on SciRah

Invite

S. Kaneko — researcher profile on SciRah

Sakura Kirino×23

Invite

Sakura Kirino — researcher profile on SciRah

Kento Inada×22

Invite

Kento Inada — researcher profile on SciRah